"Vitiligo" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder consisting of areas of macular depigmentation, commonly on extensor aspects of extremities, on the face or neck, and in skin folds. Age of onset is often in young adulthood and the condition tends to progress gradually with lesions enlarging and extending until a quiescent state is reached.
| Descriptor ID |
D014820
|
| MeSH Number(s) |
C17.800.621.440.895
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitiligo".
Below are MeSH descriptors whose meaning is more specific than "Vitiligo".
This graph shows the total number of publications written about "Vitiligo" by people in this website by year, and whether "Vitiligo" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 6 | 0 | 6 |
| 2016 | 6 | 0 | 6 |
| 2017 | 12 | 0 | 12 |
| 2018 | 5 | 0 | 5 |
| 2019 | 4 | 0 | 4 |
| 2020 | 6 | 0 | 6 |
| 2021 | 7 | 0 | 7 |
| 2022 | 7 | 0 | 7 |
| 2023 | 8 | 0 | 8 |
| 2024 | 2 | 0 | 2 |
| 2025 | 7 | 0 | 7 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitiligo" by people in Profiles.
-
Sherman S, Duskin-Bitan H, Agiv T, Bar D, Marom-Haham L, Levi A, Mimouni D, Chen LC, Harris JE, Levitt JB, Schonmann Y, Cohen AD, Netzer D. Bidirectional association between vitiligo and melasma: A large-scale population-based study. Indian J Dermatol Venereol Leprol. 2026 Mar-Apr; 92(2):150-156.
-
Long TJ, Pearson TF, Harris JE. Deciphering Depigmentation: Mouse Models for Vitiligo Research. J Invest Dermatol. 2025 Sep; 145(9):2135-2146.
-
Okamura K, Arai Y, Kawaguchi J, Tsukada S, Nakamura A, Abe Y, Fukuda K, Harris JE, Suzuki T. A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation. J Invest Dermatol. 2026 Feb; 146(2):374-382.e4.
-
Ezzedine K, Parsad D, Harris JE, van Geel N, Gardner J, Bibeau K, Gao J, Ren H, Hamzavi IH. Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey. J Dermatolog Treat. 2025 Dec; 36(1):2504082.
-
Tissera KA, Hawryluk EB, Harris J, Garza-Mayers AC. Survey of Access to and Use of Narrowband UVB Phototherapy in Pediatric Vitiligo. Pediatr Dermatol. 2025 May-Jun; 42(3):517-522.
-
Tissera KA, Buros-Stein A, Delva C, Mayur O, Hawryluk EB, Harris JE, Garza-Mayers AC. Investigation of Hearing Loss in Pediatric Vitiligo. Pediatr Dermatol. 2025 Sep-Oct; 42(5):1016-1019.
-
Tissera KA, Buros-Stein A, Delva CA, Mayur O, Hawryluk EB, Harris J, Garza-Mayers AC. No Association of Pediatric Vitiligo With Visual Acuity Deficits. Pediatr Dermatol. 2025 Mar-Apr; 42(2):318-321.
-
Ezzedine K, Tannous R, Pearson TF, Harris JE. Recent clinical and mechanistic insights into vitiligo offer new treatment options for cell-specific autoimmunity. J Clin Invest. 2025 Jan 16; 135(2).
-
Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, Goldman MP, Munavalli G, Kahn SA, Huang V, Waibel J, Desai A, Elbuluk N, Desai S, Pandya AG. Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation. J Am Acad Dermatol. 2024 Dec; 91(6):1104-1112.
-
Delva C, Pearson TF, Harris JE. Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development. Cutis. 2024 Apr; 113(4):156-158.